Cargando…
Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer
The emergence of cancer immunotherapies utilizing adoptive cell transfer (ACT) continues to be one of the most promising strategies for cancer treatment. Mast cells (MCs) which occur throughout vascularized tissues, are most commonly associated with Type I hypersensitivity, bind immunoglobin E (IgE)...
Autores principales: | Fereydouni, Mohammad, Motaghed, Mona, Ahani, Elnaz, Kafri, Tal, Dellinger, Kristen, Metcalfe, Dean D., Kepley, Christopher L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009255/ https://www.ncbi.nlm.nih.gov/pubmed/35433433 http://dx.doi.org/10.3389/fonc.2022.830199 |
Ejemplares similares
-
Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy
por: Fereydouni, Mohammad, et al.
Publicado: (2022) -
Identification and Characterization of Tunneling Nanotubes Involved in Human Mast Cell FcεRI-Mediated Apoptosis of Cancer Cells
por: Ahani, Elnaz, et al.
Publicado: (2022) -
Human Mast Cells From Adipose Tissue Target and Induce Apoptosis of Breast Cancer Cells
por: Plotkin, Jesse D., et al.
Publicado: (2019) -
Harnessing the Power of Mast Cells in unconventional Immunotherapy Strategies and Vaccine Adjuvants
por: Willows, Steven, et al.
Publicado: (2020) -
Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy
por: Sulsenti, Roberta, et al.
Publicado: (2023)